- Analysis
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.
Metrics to compare | ADR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −5.2x | −0.5x | |
PEG Ratio | −0.01 | −0.06 | 0.00 | |
Price / Book | −17.1x | 3.3x | 2.6x | |
Price / LTM Sales | 12.0x | 5.3x | 3.2x | |
Upside (Analyst Target) | - | 72.1% | 45.7% | |
Fair Value Upside | Unlock | 12.9% | 4.8% | Unlock |